Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice

Neuromuscular Disorders

Volumn 12, Issue SUPPL., 2002, Pages

  Boer, Judith M ^a   De Meijer, Emile J ^a   Mank, Eveline M ^a   Van Ommen, Gertjan B ^a   Den Dunnen, Johan T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Duchenne muscular dystrophy; Dystrophin; Expression profiling; mdx mouse; Oligonucleotide array

Indexed keywords

DYSTROPHIN; OLIGONUCLEOTIDE;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; DNA MICROARRAY; DUCHENNE MUSCULAR DYSTROPHY; ENERGY METABOLISM; EXPERIMENTAL MOUSE; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HINDLIMB; IMMUNE RESPONSE; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; SKELETAL MUSCLE; UNINDEXED SEQUENCE; UPREGULATION; X CHROMOSOME LINKAGE;

ANIMALS; DYSTROPHIN; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; REGENERATION; UP-REGULATION;

EID: 0036823511     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00092-5     Document Type: Conference Paper

References (40)

1. van Ommen G.J., Verkerk J.M., Hofker M.H., et al. A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell. 47:1986;499-504.
2. van Ommen G.J., Bertelson C., Ginjaar H.B., et al. Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics. 1:1987;329-336.
3. Monaco A.P., Neve R.L., Colletti-Feener C., Bertelson C.J., Kurnit D.M., Kunkel L.M. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature. 323:1986;646-650.
4. Hoffman E.P., Monaco A.P., Feener C.C., Kunkel L.M. Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science. 238:1987;347-350.
5. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:1987;509-517.
6. den Dunnen J.T., Grootscholten P.M., Bakker E., et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 45:1989;835-847.
7. den Dunnen J.T., Bakker E., Breteler E.G., Pearson P.L., van Ommen G.J. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature. 329:1987;640-642.
8. Koenig M., Monaco A.P., Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 53:1988;219-226.
9. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:1990;315-319.
10. Yoshida M., Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem (Tokyo). 108:1990;748-752.
11. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1991;1121-1131.
12. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
13. Hoffman E., Fischbeck K., Brown R., et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 318:1988;1363-1368.
14. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1989;1578-1580.
15. Bulfield G., Siller W.G., Wight P.A., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 81:1984;1189-1192.
16. Hoffman E.P., Brown R.H. Jr, Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
17. Hoffman E.P., Schwartz L. Dystrophin and disease. Mol Aspects Med. 12:1991;175-194.
18. Stedman H.H., Sweeney H.L., Shrager J.B., et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352:1991;536-539.
19. Thomas G.D., Sander M., Lau K.S., Huang P.L., Stull J.T., Victor R.G. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci USA. 95:1998;15090-15095.
20. Chen Y.W., Zhao P., Borup R., Hoffman E.P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol. 151:2000;1321-1336.
21. Gorospe J.R., Tharp M.D., Hinckley J., Kornegay J.N., Hoffman E.P. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J Neurol Sci. 122:1994;44-56.
22. McArdle A., Edwards R.H., Jackson M.J. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve. 17:1994;1378-1384.
23. Porter J.D., Khanna S., Kaminski H.J., et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet. 11:2002;263-272.
24. Tsai J., Sultana R., Lee Y., et al. RESOURCERER: a database for annotating and linking microarray resources within and across species. Genome Biol. 2:2001;software2.1-2.4.
25. Ashburner M., Ball C.A., Blake J.A., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25:2000;25-29.
26. Pruitt K.D., Katz K.S., Sicotte H., Maglott D.R. Introducing RefSeq and LocusLink: curated human genome resources at the NCBI. Trends Genet. 16:2000;44-47.
27. Bairoch A., Apweiler R. The SWISS-PROT protein sequence database: its relevance to human molecular medical research. J Mol Med. 75:1997;312-316.
28. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: encyclopedia for genes, proteins and diseases. In: Weizmann Institute of Science, Bioinformatics Unit and Genome Center (Rehovot, Israel): http://bioinformatics.weizmann.ac.il/cards, 1997.
29. Ricchiuti V., Apple F.S. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem. 45:1999;2129-2135.
30. Messner B., Baum H., Fischer P., Quasthoff S., Neumeier D. Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. Am J Clin Pathol. 114:2000;544-549.
31. Tkatchenko A.V., Le Cam G., Leger J.J., Dechesne C.A. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim Biophys Acta. 1500:2000;17-30.
32. Jin Y., Murakami N., Saito Y., Goto Y., Koishi K., Nonaka I. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol (Berl). 99:2000;619-627.
33. Garrett K.L., Anderson J.E. Colocalization of bFGF and the myogenic regulatory gene myogenin in dystrophic mdx muscle precursors and young myotubes in vivo. Dev Biol. 169:1995;596-608.
34. Bhagwati S., Ghatpande A., Shafiq S.A., Leung B. In situ hybridization analysis for expression of myogenic regulatory factors in regenerating muscle of mdx mouse. J Neuropathol Exp Neurol. 55:1996;509-514.
35. Zhu X., Hadhazy M., Wehling M., Tidball J.G., McNally E.M. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett. 474:2000;71-75.
36. Fang J., Shi G.P., Vaghy P.L. Identification of the increased expression of monocyte chemoattractant protein-1, cathepsin S, UPIX-1, and other genes in dystrophin-deficient mouse muscles by suppression subtractive hybridization. J Cell Biochem. 79:2000;164-172.
37. Sano M., Wada Y., Ii K., Kominami E., Katunuma N., Tsukagoshi H. Immunolocalization of cathepsins B, H and L in skeletal muscle of X-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl). 75:1988;217-225.
38. Gorospe J.R., Tharp M., Demitsu T., Hoffman E.P. Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis. Neuromuscul Disord. 4:1994;325-333.
39. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol. 11:1999;103-108.
40. Tarnopolsky M.A., Beal M.F. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol. 49:2001;561-574.